Melanoma survivors report good quality of life
Ten years, on average, after diagnosis, melanoma survivors report enjoying a good quality of life and take more care to protect themselves from sun exposure than non-patients do, a recent study indicates. The study followed subjects from a 2010 research project on risk factors for melanoma and compared 724 melanoma survivors to a control group of 660 subjects without melanoma. University of Minnesota researchers Rachel Isaksson Vogel, PhD, and DeAnn Lazovich, PhD, MPH, served as coauthors of the 2010 report and the follow-up study.
Respondents in the melanoma survivors’ group reported a marginally higher quality of life than their counterparts in the control group, Lazovich says. While they were not as cautious as physicians recommend, melanoma survivors were still more likely than the control group to protect themselves from sunburn and to spend less time in the sun. Findings on the sun protection behaviors will be published this year in Cancer Epidemiology, Biomarkers & Prevention.
Study on melanoma treatment patterns opens
Subjects are currently sought for the multisite OPTIMIzE study, which aims to understand melanoma treatment patterns and improve quality of life for metastatic melanoma patients receiving cancer therapy. The 5-year observational study will look at the selection and sequencing of drugs, dosing, duration, regimen, rationale for initial treatment decisions and treatment changes, survival rates, and other patient outcomes. M Health oncologist Evidio Domingo-Musibay, MD, is site principal investigator. For more information, contact Anne Janisch, email@example.com.
Dermatologic surgeon joins M Health
Amanda J. Tschetter, MD, joins University of Minnesota Health Dermatology Clinic as a dermatologic surgeon. Her interests include dermatologic oncology—treating skin cancers such as melanoma, basal cell carcinoma, squamous cell carcinoma, and Merkel cell carcinoma—as well as cosmetic dermatology. She completed medical school at the University of South Dakota’s Sanford School of Medicine, her residency at the University of Iowa, and a fellowship at Zitelli and Brodland Skin Cancer Center in Pittsburgh. Tschetter is certified by the American Board of Dermatology.
A minimally invasive approach to dissecting affected inguinal lymph nodes and new immunotherapies under clinical trial review show promise in treating an increasingly common form of cancer.Continue reading
A patient with melanoma undergoes a minimally invasive femoral lymph dissection. Discharged the same day, she experienced no wound complications and remains free of melanoma recurrence.Continue reading